Legend Biotech (LEGN) EBITDA Margin (2020 - 2026)
Legend Biotech (LEGN) recorded EBITDA Margin of 15.92% in Q2 2026, up 23.57 percentage points from -7.64% a year earlier and up 31.46 percentage points from the prior quarter.
Powered by 
Analysis
Legend Biotech (LEGN) EBITDA Margin (2020 - 2026) Analysis & Trends
On a TTM basis, Legend Biotech's EBITDA Margin came in at -3.47% as of Jun 30, 2026, up 23.22 percentage points year-over-year; for FY2025, it came in at -12.35%, up 34.97 percentage points from FY2024.
- Annual EBITDA Margin has a five-year change of -453.26 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at -47.32% in FY2024 (+133.48 pp), -180.81% in FY2023 (-591.53 pp), 410.73% in FY2022 (-226.61 pp) and 637.33% in FY2021 (+196.43 pp).
- The Q2 2026 figure is the highest quarterly EBITDA Margin since Q2 2024.
- On a year-over-year basis, EBITDA Margin has increased for four consecutive quarters, with an average year-over-year change of -98.70 percentage points over the last eight quarters.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 1840.50 percentage points in Q2 2023, against a drop of 1161.05 percentage points in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at -15.54% (Q1 2026), -5.55% (Q4 2025) and -15.18% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 39.10% |
| 10 | Legend Biotech | 3.47 Bn | -271.48 Mn | 251.50 Mn | 15.92% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15.92% |
| Mar 31, 2026 | -15.54% |
| Dec 31, 2025 | -5.55% |
| Sep 30, 2025 | -15.18% |
| Jun 30, 2025 | -7.64% |
| Mar 31, 2025 | -25.27% |
| Dec 31, 2024 | -40.85% |
| Sep 30, 2024 | -42.23% |
| Jun 30, 2024 | 156.71% |
| Mar 31, 2024 | 193.07% |
| Dec 31, 2023 | 232.32% |
| Sep 30, 2023 | 187.13% |
| Jun 30, 2023 | 227.06% |
| Mar 31, 2023 | 307.58% |
| Dec 31, 2022 | 417.77% |
| Sep 30, 2022 | 487.66% |
| Jun 30, 2022 | -1,613.44% |
| Mar 31, 2022 | -65.31% |
| Dec 31, 2021 | -227.05% |
| Sep 30, 2021 | -723.79% |
API Access
Legend Biotech EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=LEGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "LEGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=LEGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();